BSPED2025 Poster Presentations Bone (8 abstracts)
1Mid Yorkshire Teaching Hospital NHS Trust, Wakefield, United Kingdom; 2Leeds Childrens Hospital, Leeds, United Kingdom; 3Leeds Institute for Data Analytics, Leeds, United Kingdom; 4Birmingham Childrens Hospital, Birmingham, United Kingdom; 5Centre for Cancer Immunology, Southampton, United Kingdom; 6Southampton Childrens Hospital, Southampton, United Kingdom
Introduction: The British Osteonecrosis Study (BONES) is the first multicentre prospective study assessing bone health and vertebral fractures in patients aged 10-24 in the UK undergoing treatment for acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL).
Methods: 61 patients were recruited from 3 tertiary centres in the UK. Dual-energy x-ray absorptiometry (DXA) scans with vertebral fracture analysis were performed within 4 weeks of diagnosis and annually for 3 years. Subjective pain assessments were performed at the same timepoints.
Results: Bone mineral density (assessing total body less head (TBLH) significantly reduced after 2-years, compared to baseline (estimate = -0.964, 95% CI [-1.357, -0.572]), with greatest decrease occurring within the first year. Vertebral fracture prevalence was 4.9%, with 2 further patients experiencing incident vertebral fractures. All vertebral fractures occurred in male patients, 75% of whom were British Asian. Back pain was not a predictor of low BMD or vertebral fractures.
Discussion: We report a lower vertebral fracture prevalence in patients aged 10-24 with ALL than has been previously reported in a cohort of younger patients. Male British Asian patients appeared to be at higher risk of vertebral fractures in this study. BMD and pain were not predictors of vertebral fractures.